Orion Portfolio Solutions LLC lowered its position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 3.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 11,354 shares of the medical device company’s stock after selling 390 shares during the period. Orion Portfolio Solutions LLC’s holdings in Cooper Companies were worth $1,253,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Victory Capital Management Inc. grew its position in shares of Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after buying an additional 737,726 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in Cooper Companies by 3.7% in the 2nd quarter. Envestnet Asset Management Inc. now owns 758,332 shares of the medical device company’s stock worth $66,202,000 after purchasing an additional 26,787 shares in the last quarter. TD Asset Management Inc acquired a new stake in Cooper Companies in the 2nd quarter worth approximately $53,045,000. Qsemble Capital Management LP acquired a new stake in Cooper Companies in the 2nd quarter worth approximately $4,078,000. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its stake in Cooper Companies by 60.9% in the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 38,065 shares of the medical device company’s stock worth $3,323,000 after purchasing an additional 14,413 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.
Insider Buying and Selling
In other news, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares of the company’s stock, valued at $18,267,624.69. This represents a 41.03 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.00% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Report on COO
Cooper Companies Price Performance
NASDAQ:COO opened at $94.85 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market cap of $18.93 billion, a price-to-earnings ratio of 48.64, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97. The company has a 50 day moving average price of $103.49 and a 200-day moving average price of $98.92. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.87 EPS. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
See Also
- Five stocks we like better than Cooper Companies
- Dividend Payout Ratio Calculator
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is a Low P/E Ratio and What Does it Tell Investors?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is the Australian Securities Exchange (ASX)
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.